Conti, Valentino
Rossi, Omar http://orcid.org/0000-0002-0170-1285
Clarkson, Kristen A.
Mancini, Francesca
Nakakana, Usman N. http://orcid.org/0000-0002-4885-9485
Sarakinou, Eleanna
Callegaro, Andrea
Ferruzzi, Pietro
Acquaviva, Alessandra
Arora, Ashwani Kumar
Marchetti, Elisa
Necchi, Francesca
Frenck, Robert W. Jr
Martin, Laura B.
Kaminski, Robert W.
Podda, Audino
Micoli, Francesca http://orcid.org/0000-0001-8243-3181
Funding for this research was provided by:
Bill and Melinda Gates Foundation
Article History
Received: 31 August 2023
Accepted: 30 January 2024
First Online: 8 March 2024
Competing interests
: V.C., O.R., F.Ma., U.N., E.S., A.C., P.F., A.A., A.K.A., E.M., F.N., L.B.M., A.P., and F.Mi. are or were GSK employees when the study was designed, initiated, and/or conducted. V.C., O.R., A.K.A., F.N., and F.Mi. hold shares in GSK. L.B.M. reports paid travel costs by BMGF to attend <i>Shigella</i> meetings in January 2020. P.F. reports grants/contracts to GSK from BMGF. L.B.M. and F.Mi. report funding to GSK from BMGF for vaccine manufacturing and testing and patent issued on the 4-component <i>Shigella</i> GMMA formulation. K.A.C., R.W.F., and R.W.K. have no financial relationships to disclose. The authors declare no other financial and non-financial relationships and activities or conflicts of interest.